Correspondence 0000950170-24-101964 from Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc.
Date: Aug. 29, 2024 · CIK: 0000926617 · Accession: 0000950170-24-101964
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281745
Letter
Aspira Women’s Health, Inc.
12117 Bee Caves Road, Building III, Suite 100
Austin, Texas
August 29, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re:
Aspira Women’s Health, Inc.
Registration Statement on Form S-3
Filed August 23, 2024
File No. 333-281745
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aspira Women’s Health, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Tuesday, September 3, 2024, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
ASPIRA WOMEN’S HEALTH, INC.
By:
/s/ Nicole Sandford
Name:
Nicole Sandford
Title:
Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Aspira Women’s Health, Inc.
12117 Bee Caves Road, Building III, Suite 100
Austin, Texas
August 29, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re:
Aspira Women’s Health, Inc.
Registration Statement on Form S-3
Filed August 23, 2024
File No. 333-281745
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aspira Women’s Health, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Tuesday, September 3, 2024, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
ASPIRA WOMEN’S HEALTH, INC.
By:
/s/ Nicole Sandford
Name:
Nicole Sandford
Title:
Chief Executive Officer